Tumor-infiltrating T lymphocytes, particularly the CD4+ and CD8+ T cells, and their immunoregulatory cytokines, representing adaptive immunity, execute key effector cytotoxic functions in the tumor microenvironment and mediate responses to immune checkpoint inhibition [125]. The gene discussed is CD4; the disease is neoplasm.